Skip to main content
TipRanks
Go Ultimate75% OFF

Royalty Pharma (RPD) Ownership - Who Owns Royalty Pharma?

6 Followers

Royalty Pharma (RPD) Ownership Overview

  • 1.57% Insiders
  • 21.48% Mutual Funds
  • 33.12% Other Institutional Investors
  • 11.83% ETFs
  • 32.00% Public Companies and Individual Investors

The ownership structure of Royalty Pharma (DE:RPD) stock is a mix of institutional, retail, and individual investors. Approximately 66.43% of the company’s stock is owned by Institutional Investors, 1.57% is owned by Insiders, and 32.00% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Goalvest Advisory Llc€20,633
Dec 31, 2025Woodline Partners Lp€287,327
Dec 31, 2025Viewpoint Investment Partners Corp€328,440
Dec 31, 2025Hussman Strategic Advisors Inc€2,434,320

Top Shareholders

DE:RPD top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.29,117,396Institution6.54%2,005,489,767
New Perspective Fund19,645,749Institution4.41%1,353,120,608
Ishares15,689,991Institution3.52%1,080,663,820
Vanguard8,902,245Institution2.00%613,151,027
Growth Fund Of America7,986,638Institution1.79%550,087,679
Capital Income Builder7,427,586Institution1.67%511,582,413
Morgan Stanley Institutional Fund Inc5,418,075Institution1.22%373,175,334
Fidelity Concord Street Trust5,252,818Institution1.18%361,793,093
Pablo G. Legorreta4,954,404Insider1.11%341,239,530
Vanguard Index Funds4,471,210Institution1.00%307,959,060

Top Mutual Fund Holders

DE:RPD top mutual fund holders
Holder# of SharesType% HoldingValue
New Perspective Fund19,645,749Institution4.41%1,353,120,608
Growth Fund Of America7,986,638Institution1.79%550,087,679
Capital Income Builder7,427,586Institution1.67%511,582,413
Morgan Stanley Institutional Fund Inc5,418,075Institution1.22%373,175,334
Fidelity Concord Street Trust5,252,818Institution1.18%361,793,093
Vanguard Index Funds4,471,210Institution1.00%307,959,060
T. Rowe Price Value Fund, Inc.3,124,945Institution0.70%215,233,712
Fidelity Salem Street Trust2,810,085Institution0.63%193,547,414
Fidelity Securities Fund2,710,400Institution0.61%186,681,510
Transamerica Funds2,404,531Institution0.54%165,614,477

FAQ

Who Owns Royalty Pharma (DE:RPD)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 66.43% of the company's stock is held by institutional investors, 1.57% is held by insiders, and 32.00% is held by public companies and individual investors.
What percentage of Royalty Pharma (DE:RPD) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 66.43% of Royalty Pharma (DE:RPD) stock is held by institutional investors: 21.48% by mutual funds, 11.83% by ETFs and 33.12% by other institutional investors.
What percentage of Royalty Pharma (DE:RPD) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 32.00% of Royalty Pharma (DE:RPD) stock is held by public companies and individual investors.
Who owns the most shares of Royalty Pharma (DE:RPD)?
BlackRock, Inc. owns the most shares of Royalty Pharma (DE:RPD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.